#mounjaro
13 stories
Woman warns retatrutide nearly killed her
TikTok user Lyndsey Jones says retatrutide dosing mistake left her paralyzed and near death.
LADbible · 1m
Sorority Rush Gets Ozempic Makeover
College women use weight-loss injections to compete in sorority rush.
Fox News · 2m
Eli Lilly Price Target Boost
Berenberg upgrades Eli Lilly to Buy with 20% upside potential.
Yahoo Finance · 1m
Mounjaro Muscle Loss Guide
How to keep muscle while losing weight with Mounjaro.
Wellbeing Magazine · 1m
Eli Lilly Q2 2026 Revenue Surge
Lilly's Mounjaro revenue nearly doubled to $9.94 billion in Q2 2026, driving 48% revenue growth.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Hundreds of Lawsuits Claim GLP-1s Caused Permanent Vision Loss
Hundreds of lawsuits allege GLP-1 weight-loss drugs caused permanent vision loss.
Valleynewslive · 1m
Travelling with weight loss medication: 12 things I wish I’d known
How to travel safely with weight loss injections like Mounjaro.
Wellbeing Magazine · 2m
Eli Lilly's Tough Month: Bank Predicts 37% Gains
Citi forecasts 37% stock gains for Eli Lilly as selloff ends.
24/7 Wall St. · 1m
GLP-1 Users Face Rare Vision Loss Risk
GLP-1 drugs may cause rare vision loss, but benefits outweigh risks for most.
ABC7 New York · 1m
Eli Lilly's $1500 Target Surprises Wall Street
Eli Lilly's revenue growth outpaces stock price, with analysts missing a $1500 target by 2027
24/7 Wall St. · 1m
Nvidia vs. Eli Lilly: Which Stock Wins Next Decade?
Nvidia's AI infrastructure and Eli Lilly's GLP-1 drugs both surged, but which stock has the cleaner path to 10-year growth?
24/7 Wall St. · 1m
Eli Lilly's obesity bet hinges on September 30 data
A two-drug combo could justify Lilly's trillion-dollar valuation, but the mid-stage trial results will determine if it's a breakthrough or an expensive gamble.
24/7 Wall St. · 1m
Fasting on GLP-1 drugs: What you need to know for Yom Kippur
Millions take Ozempic and similar medications, adding a medical twist to religious fasts that require careful planning.
The Conversation · 2m